Ipamorelin + Tesamorelin stack
A research-context overview of stacking Ipamorelin with Tesamorelin: the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.
Why this stack?
Stacking a Metabolic agent (Tesamorelin) with a Performance / GH-axis compound (Ipamorelin) is the canonical body-recomposition pattern: the GLP-1 / metabolic compound drives caloric deficit and visceral-fat reduction, while the GH-axis compound preserves lean mass and accelerates training-tissue repair under that deficit. Researchers running this pair typically titrate the metabolic agent up first, then layer the GH-axis compound once dose tolerance is established.
Ipamorelin
Gentle GH releaser that amps muscle growth and fat loss without the harsh sides.
Key benefits
- ✓Increases lean muscle mass
- ✓Accelerates fat loss
- ✓Improves sleep quality
- ✓Enhances recovery
Side effects to watch
- ⚠Flushing
- ⚠Headache
- ⚠Lightheadedness
Tesamorelin
Trims visceral fat while boosting IGF-1 levels, great for shredded longevity looks.
Key benefits
- ✓Reduces visceral fat
- ✓Increases IGF-1
- ✓Improves lipid profile
- ✓Nootropic effects
Side effects to watch
- ⚠Injection site reactions
- ⚠Joint pain
- ⚠Muscle pain
Half-life considerations
Ipamorelin clears at roughly t½ 2.0 h, while Tesamorelin clears at roughly t½ 30 min. Half-lives are within an order of magnitude of each other, so peak windows can overlap if the two compounds are dosed simultaneously. Many researchers stagger by several hours to keep the peak signaling distinct.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.